STOCK TITAN
  1. Home
  2. News
  3. BMY

Bristol-Myers Squibb Co. - BMY STOCK NEWS

IMPACT
SENTIMENT
BMY : NYSE
Bristol Myers Squibb Announces Dividend
dividends
IMPACT
SENTIMENT
BMY : NYSE
Samsung Biologics announces expanded strategic agreement with Bristol Myers Squibb to manufacture an antibody cancer drug substance
IMPACT
SENTIMENT
BMY : NYSE
Bristol Myers Squibb Highlights Advancing Pipeline and Differentiated Research Platforms to Support Long-Term Sustainable Growth at R&D Day
IMPACT
SENTIMENT
BMY : NYSE
Six-Year Outcomes from Phase 3 CheckMate -227 Trial Show Durable, Long-Term Survival with Opdivo (nivolumab) Plus Yervoy (ipilimumab) in the First-Line Treatment of Patients with Metastatic Non-Small Cell Lung Cancer
clinical trial
IMPACT
SENTIMENT
BMY : NYSE
Bristol Myers Squibb’s Investigational LPA1 Antagonist Reduces Rate of Lung Function Decline in Progressive Pulmonary Fibrosis Cohort of Phase 2 Study
clinical trial
IMPACT
SENTIMENT
BMY : NYSE
Bristol Myers Squibb Celebrates a Decade of Its Coast 2 Coast 4 Cancer Cross-Country Bike Ride in Support of the V Foundation for Cancer Research
IMPACT
SENTIMENT
BMY : NYSE
Bristol Myers Squibb to Participate in the Morgan Stanley 21st Annual Global Healthcare Conference
conferences
IMPACT
SENTIMENT
BMY : NYSE
U.S. FDA Approves Bristol Myers Squibb’s Reblozyl® (luspatercept-aamt) as First-Line Treatment of Anemia in Adults with Lower-Risk Myelodysplastic Syndromes (MDS) Who May Require Transfusions
fda approval
IMPACT
SENTIMENT
BMY : NYSE
Long-Term Follow-Up Data from Two Phase 3 Studies of CAMZYOS® (mavacamten) Demonstrate Consistent and Durable Response in Patients with Symptomatic Obstructive Hypertrophic Cardiomyopathy (HCM)
clinical trial
IMPACT
SENTIMENT
BMY : NYSE
Cellares Announces Bristol Myers Squibb has Joined Technology Adoption Partnership Program to Evaluate Automated Manufacturing of CAR-T Cell Therapy on the Cell Shuttle Platform
partnership
Stock BMY logo
Bristol-Myers Squibb Co.

NYSE:BMY

BMY Rankings

#117 Ranked by Market Cap
#4058 Ranked by Stock Gains
#666 Ranked by Dividends

BMY Stock Data

Pharmaceutical Preparation Manufacturing
Manufacturing
Link
US
New York

About BMY

The Bristol-Myers Squibb Company is an American multinational pharmaceutical company. Headquartered in New York City, BMS is one of the worlds largest pharmaceutical companies and consistently ranks on the Fortune 500 list of the largest U.S. corporations. For fiscal 2022, it had a total revenue of $46.2 billion.